Washington, D.C. (May 19, 2020) -- Perhaps more than in any other case since Joe Simons became chairman of the Federal Trade Commission, the 3-2 decision approving drugmaker AbbVie’s $63 billion buyout of rival Allergan reveals his unhappiness with the dissents of his Democratic colleagues....